Buyer
Seller
ITC-HSN: 3004
Min Order Qty 100000 UNT (Unit)
Product not available
Flange Pharmaceuticals Private Limited, a leading player in the Indian pharmaceutical industry, has announced the launch of Ofpod O, a cutting-edge antibiotic combination tablet containing Cefpodoxime 200 mg and Ofloxacin 200 mg. This innovative formulation is poised to revolutionize the treatment of various bacterial infections.
Ofpod O is meticulously crafted to address the growing challenge of antibiotic resistance, a global health concern. The synergistic combination of Cefpodoxime and Ofloxacin provides broad-spectrum antibacterial activity, effectively targeting a wide range of pathogens.
Flange Pharmaceuticals Private Limited
Varanasi, India
Business Operations: Manufacturer, Merchant
Contact us for
Potent Combination: The unique blend of Cefpodoxime and Ofloxacin ensures optimal efficacy against a wide spectrum of bacteria.
Rapid Action: Designed for quick absorption and rapid onset of action, providing faster relief from infection symptoms.
Convenient Dosage: The tablet formulation offers a convenient and easy-to-administer dosage for patients.
With its strong research and development capabilities, Flange Pharmaceuticals is dedicated to delivering high-quality, affordable medicines to patients across India. The company is confident that Ofpod O will make a significant contribution to improving patient outcomes and public health.
Established in: | 2016 |
Bussiness Type: | Private Limited |
Bussiness Type: | Manufacturer, Merchant |
MSME: | Yes |
Export Turnover (3 years): | Less than US$10,000 |
Countries would like to export to: | Afghanistan, Australia, Central African Republic, Germany, Nigeria, Qatar, South Africa, United Arab Emirates |
No of employees: | 1-10 |